Related Experiment Videos

Treatment of intracranial ependymoma by surgery alone

J Hukin1, F Epstein, D Lefton

  • 1Department of Neurology, Beth Israel Medical Center, New York, N.Y., USA.

Pediatric Neurosurgery
|October 2, 1998
PubMed

Insights

Deferring radiotherapy after complete surgical removal of pediatric intracranial ependymoma is safe. Most children remained disease-free, and recurrences were treatable with further surgery and radiotherapy.

Area of Science:

  • Pediatric neuro-oncology
  • Radiation oncology
  • Neurosurgery

Background:

  • Ependymomas are a significant cause of brain tumors in children.
  • Standard treatment often includes surgery followed by radiotherapy.
  • The role of radiotherapy in localized ependymoma after gross total resection requires further investigation.

Purpose of the Study:

  • To evaluate the safety and efficacy of withholding radiotherapy in pediatric patients with intracranial ependymoma.
  • To assess outcomes in patients who underwent gross total resection and deferred radiotherapy.
  • To determine recurrence patterns and salvageability in this patient cohort.

Main Methods:

  • Prospective study of children over age 3 diagnosed with intracranial ependymoma.
  • Inclusion criteria: radiographically confirmed gross total resection.
  • Data collected on disease recurrence, salvage treatment, and survival.

Main Results:

  • Ten patients were eligible and consented to participate.
  • Seven patients remained disease-free without additional treatment.
  • Three patients experienced recurrence; two were successfully treated with surgery and radiotherapy, with no deaths.

Conclusions:

  • Radiotherapy deferral is a safe strategy for pediatric supratentorial ependymomas following gross total resection.
  • Recurrences are typically local and amenable to salvage therapy.
  • This approach may help reduce long-term treatment-related toxicities in select pediatric patients.
Abstract

Related Concept Videos